Viaderma Company Executives
| VDRM Stock | USD 0.01 0.0004 4.44% |
Viaderma employs about 8 people. The company is managed by 6 executives with a total tenure of roughly 55 years, averaging almost 9.0 years of service per executive, having 1.33 employees per reported executive. Analysis of Viaderma's management performance can provide insight into the firm performance.
| Shaowen Zhang Executive Manager of Production |
| Christopher Otiko Insider Chief Founder |
Viaderma |
Viaderma Management Team Effectiveness
The company has return on total asset (ROA) of (0.9123) % which means that it has lost $0.9123 on every $100 spent on assets. This is way below average. Viaderma's management efficiency ratios could be used to measure how well Viaderma manages its routine affairs as well as how well it operates its assets and liabilities.Viaderma Workforce Comparison
Viaderma is rated first in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 50.0. Viaderma retains roughly 8.0 in number of employees claiming about 16% of equities under Drug Manufacturers—Specialty & Generic industry.
Viaderma Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Viaderma Price Series Summation is a cross summation of Viaderma price series and its benchmark/peer.
Viaderma Notable Stakeholders
A Viaderma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Viaderma often face trade-offs trying to please all of them. Viaderma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Viaderma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Zhang Xie | Corporate Secretary and Director | Profile | |
| Qing Lin | CFO and Director | Profile | |
| Shaowen Zhang | Manager of Production | Profile | |
| Christopher Otiko | Chief Founder | Profile | |
| Baotang Zhao | Chief Sales Officer | Profile | |
| MPH MD | Medical Board | Profile |
About Viaderma Management Performance
The success or failure of an entity such as Viaderma often depends on how effective the management is. Viaderma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Viaderma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Viaderma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Viaderma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Viaderma Workforce Analysis
Traditionally, organizations such as Viaderma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Viaderma within its industry.Viaderma Manpower Efficiency
Return on Viaderma Manpower
| Revenue Per Employee | 5.6K | |
| Revenue Per Executive | 7.4K | |
| Net Loss Per Employee | 189.8K | |
| Net Loss Per Executive | 253.1K |
Other Information on Investing in Viaderma Pink Sheet
Viaderma financial ratios help investors to determine whether Viaderma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viaderma with respect to the benefits of owning Viaderma security.